These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. Pearlson GD; Jeffery PJ; Harris GJ; Ross CA; Fischman MW; Camargo EE Am J Psychiatry; 1993 Mar; 150(3):495-7. PubMed ID: 8434669 [TBL] [Abstract][Full Text] [Related]
43. Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice. Marinho EA; Oliveira-Lima AJ; Santos R; Hollais AW; Baldaia MA; Wuo-Silva R; Yokoyama TS; Takatsu-Coleman AL; Patti CL; Longo BM; Berro LF; Frussa-Filho R Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():22-31. PubMed ID: 25496830 [TBL] [Abstract][Full Text] [Related]
44. Substance abuse and cerebral blood flow. Mathew RJ; Wilson WH Am J Psychiatry; 1991 Mar; 148(3):292-305. PubMed ID: 1992832 [TBL] [Abstract][Full Text] [Related]
45. Pathophysiology of drug dependence. Galynker II; Goldfarb CR; Ongseng F; Finestone H J Nucl Med; 1996 Dec; 37(12):2098. PubMed ID: 8970542 [No Abstract] [Full Text] [Related]
46. Amphetamine et al. O'Shea B Ir Med J; 2000 Jun; 93(4):100-1. PubMed ID: 11037564 [No Abstract] [Full Text] [Related]
47. Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HMPAO and ASPECT. Holman BL; Carvalho PA; Mendelson J; Teoh SK; Nardin R; Hallgring E; Hebben N; Johnson KA J Nucl Med; 1991 Jun; 32(6):1206-10. PubMed ID: 2045934 [TBL] [Abstract][Full Text] [Related]
48. Neurotransmitter transporters as molecular targets for addictive drugs. Amara SG; Sonders MS Drug Alcohol Depend; 1998; 51(1-2):87-96. PubMed ID: 9716932 [TBL] [Abstract][Full Text] [Related]
49. Imaging receptor changes in human drug abusers. Cosgrove KP Curr Top Behav Neurosci; 2010; 3():199-217. PubMed ID: 21161754 [TBL] [Abstract][Full Text] [Related]
50. Predisposition to addiction: pharmacokinetics, pharmacodynamics, and brain circuitry. Kalivas PW Am J Psychiatry; 2003 Jan; 160(1):1-2. PubMed ID: 12505792 [No Abstract] [Full Text] [Related]
51. Radiological and neurological changes in the drug abuse patient: a study with MRI. Volkow ND; Valentine A; Kulkarni M J Neuroradiol; 1988; 15(3):288-93. PubMed ID: 3266757 [TBL] [Abstract][Full Text] [Related]
52. Evidence for a relationship between Group 1 mGluR hypofunction and increased cocaine and ethanol sensitivity in Homer2 null mutant mice. Szumlinski KK; Toda S; Middaugh LD; Worley PF; Kalivas PW Ann N Y Acad Sci; 2003 Nov; 1003():468-71. PubMed ID: 14684491 [No Abstract] [Full Text] [Related]
53. A behavioral/systems approach to the neuroscience of drug addiction. White FJ J Neurosci; 2002 May; 22(9):3303-5. PubMed ID: 11978803 [No Abstract] [Full Text] [Related]
54. Radioligands for brain 5-HT2 receptor imaging in vivo: why do we need them? Busatto GF Eur J Nucl Med; 1996 Aug; 23(8):867-70. PubMed ID: 8753673 [No Abstract] [Full Text] [Related]
55. Regional cerebral blood flow imaging with SPECT in psychiatric disease: focus on schizophrenia, anxiety disorders, and substance abuse. Woods SW J Clin Psychiatry; 1992 Nov; 53 Suppl():20-5. PubMed ID: 1459979 [TBL] [Abstract][Full Text] [Related]
56. "Sexy stimulants": the interaction between psychomotor stimulants and sexual behavior in the female brain. Guarraci FA; Bolton JL Pharmacol Biochem Behav; 2014 Jun; 121():53-61. PubMed ID: 24269964 [TBL] [Abstract][Full Text] [Related]
57. The pharmacology of mood-altering drugs of abuse. Carr LA Prim Care; 1993 Mar; 20(1):19-31. PubMed ID: 8464940 [TBL] [Abstract][Full Text] [Related]